Skip to content

RYTM

Rhythm Pharmaceuticals, Inc.

Stock

$92.83−0.58 (−0.62%)Close Oct 2, 2026

Net income, 2025
−$197M

Net income

Net income by fiscal year

PeriodNet incomeYoY
2025−$197M—
2024−$261M—
2023−$185M—
2022−$181M—
2021−$70M—
2020−$134M—
2019−$141M—
2018−$74M—
2017−$34M—
2016−$26M—
2015−$11M—